Antithrombotic prophylaxis with rivaroxaban in patients with prehospital COVID-19: A meta-analysis of two placebo-controlled trials
Description
Background We conducted a prespecified meta-analysis of two randomized, placebo-controlled trials of rivaroxaban 10 mg daily in prehospital patients with acute COVID-19. Individually, the trials had limited power to detect a treatment effect due to
